1. 鼻咽癌中 Period2下调 ERK/MAPK 磷酸化水平的机制.
- Author
-
张志娟, 马政, 康晶, 杨敬, 徐倩茹, 牛欣冉, 罗小丫, 王婧媛, 李海亮, and 侯丽
- Abstract
Objective To investigate the molecular mechanism by which the circadian clock gene Period2 (PER2) downregulates extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) phosphorylation levels in nasopharyngeal carcinoma (NPC). Methods Cells were infected with lentivirus to construct cell lines. The expression of PER2 protein was validated using label-free proteomic analysis. Different concentrations of the ERK pathway activator Ceramide C6 were used to intervene with the cells, and the optimal drug concentration and treatment time were determined based on cell proliferation assessed by MTT assay. Western blotting was performed to detect the expression of PER2, ERK, p38 MAPK, p-ERK, and p-p38 MAPK proteins in cells after intervention with Ceramide C6, with the normal control group treated with an equal amount of drug solvent. Flow cytometry was used to analyze the cell cycle, and Transwell assay was conducted to evaluate cell invasion ability, further elucidating the mechanism by which PER2 regulates ERK and MAPK phosphorylation. Immunohistochemistry was employed to detect the expression of PER2 and p-ERK proteins in human NPC samples, and the correlation between PER2, p-ERK expression, and clinical characteristics of NPC was analyzed. Results Proteomic analysis showed that the expression of PER2 protein was significantly higher in the PER2 overexpression (OE) group compared to the negative virus control group and blank control group (P<0.05). The top 20 differentially expressed proteins revealed that MAPK3 exhibited significant differences between the PER2 OE group and control group (P<0.05). MTT assay results indicated that the optimal drug concentration was 10 μM, with the optimal treatment time being 24 hours. Western blotting results showed that PER2 overexpression downregulated the expression of p-ERK and p-p38 MAPK proteins, and intervention with Ceramide C6 led to upregulation of p-ERK and p-p38 MAPK protein expression levels in the PER2-OE group, with significant differences before and after intervention (P<0.01). Cell cycle analysis revealed that intervention with Ceramide C6 increased the proportion of cells in the G1 phase and decreased the number of cells in the G2 phase. Transwell assay results demonstrated that PER2 overexpression inhibited cell invasion ability, which could not be reversed by kinase. Immunohistochemistry showed significant differences in the expression rates of PER2 and p-ERK proteins in NPC tissues and nasopharyngeal mucosa (P<0.05). The expression of PER2 protein was correlated with tumor T stage (P<0.05) and positively correlated with p-ERK protein expression in NPC tissues (P<0.05). Conclusion PER2 overexpression downregulates ERK/MAPK phosphorylation levels, possibly not by directly affecting the phosphorylation sites of ERK and p38 MAPK, but by regulating key nodes of ERK and p38 MAPK. PER2 protein is downregulated and p-ERK protein is upregulated in NPC tissues, and they are correlated, closely related to the occurrence and development of tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF